• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Amgen Ventures

edit

As a company formed with venture capital funding more than 25 years ago, they understand the challenges faced by early-stage biotechnology companies. In 2004, they announced the formation of Amgen Ventures, their corporate venture capital fund. With an initial investment of $100 million, the fund is designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics. Amgen Ventures reflects Amgen’s commitment to helping patients by transforming cutting-edge scientific discoveries into novel treatments for serious illness.

Recent Milestones

edit

• 
  Amgen Ventures invested in Opsona. (4/29/13)
  Posted 5/1/13 at 7:34pm via finsmes.com
• 
  Amgen Ventures invested in Theraclone Sciences. (3/25/13)
  Posted 3/25/13 at 8:12pm via finsmes.com
• 
  Amgen Ventures invested in Sutro Biopharma. (5/8/12)
  Posted 5/8/12 at 5:57am via yahoo.com
• 
  Amgen Ventures invested in Miragen Therapeutics. (4/24/12)
  Posted 4/24/12 at 5:51pm via finsmes.com
• 
  Amgen Ventures invested in Ardelyx. (8/31/11)
  Posted 8/31/11 at 6:21pm via ardelyx.com
• 
  Amgen Ventures invested in Oncofactor Corporation. (8/2/11)
  Posted 5/24/11 at 3:33am via onbiovc.com
• 
  Amgen Ventures invested in Acylin Therapeutics. (1/11/11)
  Posted 1/19/11 at 9:44pm via onbiovc.com
• 
  Amgen Ventures invested in Sutro Biopharma. (11/17/10)
  Posted 11/17/10 at 6:25pm via finsmes.com
• 
  Amgen Ventures invested in DecImmune Therapeutics. (9/27/10)
  Posted 9/27/10 at 11:08pm via finsmes.com
• 
  Amgen Ventures invested in TetraLogic Pharmaceuticals. (8/10/10)
  Posted 8/10/10 at 5:26pm via fiercebiotech.com
• 
  Amgen Ventures invested in Calistoga Pharmaceuticals. (6/30/10)
  Posted 6/30/10 at 5:59pm via calistogapharma.com
• 
  Amgen Ventures invested in Theraclone Sciences. (3/17/10)
  Posted 7/22/10 at 7:17pm via xconomy.com
• 
  Amgen Ventures invested in Trinity Biosystems. (11/9/09)
  Posted 11/10/09 at 1:46am via venturebeat.com
• 
  Amgen Ventures invested in Epizyme. (10/7/09)
  Posted 10/7/09 at 2:46pm via fiercebiotech.com
• 
  Amgen Ventures invested in Miragen Therapeutics. (6/3/09)
  Posted 6/17/09 at 10:36am via biospace.com
• 
  Amgen Ventures invested in Calistoga Pharmaceuticals. (5/5/09)
  Posted 7/7/09 at 12:25pm

Investments

Videos

Sources

1. Opsona Therapeutics Raises €33M in Series C Financing (finsmes.com) [edit]
2. Theraclone Sciences Closes $14M in Series B and Debt Financing (finsmes.com) [edit]
3. Sutro Closes $16.5 Million Second Tranche of Series C Financing (finance.yahoo.com) [edit]
4. MiRagen Therapeutics Completes $20M Series B Financing (finsmes.com) [edit]
5. Ardelyx, Inc. Closes $30M Series B Financing (ardelyx.com) [edit]
6. Oncofactor, Inc.: Series A $2.1M (onbiovc.com) [edit]
7. Acylin Therapeutics, Inc.: Series A $4.4M (onbiovc.com) [edit]
8. Sutro Biopharma Secures $36.5M in Series C Financing (finsmes.com) [edit]
9. DecImmune Therapeutics Receives $1M in Equity Financing; $2.2M Phase II SBIR Funding (finsmes.com) [edit]
10. TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com) [edit]
11. Calistoga Pharmaceuticals Raises $40 Million in Series C Financing (calistogapharma.com) [edit]
12. Theraclone Raises $1.5M (xconomy.com) [edit]
13. Trinity Biosystems raises $7.5M bridge to treat endocrine disorders (deals.venturebeat.com) [edit]
14. Epizyme pulls in $32M in VC capital, new investors (fiercebiotech.com) [edit]
15. biospace.com [edit]
16. Capital Report Index [edit]
17. InteKrin raises $18.5M for continued work on diabetes drug (deals.venturebeat.com) [edit]
18. Allozyne, Inc., Closes $30 Million Series B Financing (allbusiness.com) [edit]
19. Argolyn Bioscience Raises $15.8 Million Round of Financing (salesandmarketingnetwork.com) [edit]
20. Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of a $21 million Series A financing (calistogapharma.com) [edit]
21. EDGAR [edit]
22. VLST Corporation Raises $55 Million (vlstcorp.com) [edit]
23. Viron Therapeutics raises US $20 million (vironinc.com) [edit]
24. AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS (freshnews.com) [edit]
25. Allozyne Inc. Raises $3.5 Million in Series A Funding (goodwinprocter.com) [edit]
26. PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING (ptct.client.shareholder.com) [edit]
27. AVIDIA ADVANCING LEAD PRODUCT THROUGH $28.5M SERIES B ROUND. (thefreelibrary.com) [edit]